Show
Sort by
-
ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males
-
Investigation, treatment and monitoring of late-onset hypogonadism in males
-
- Journal Article
- A1
- open access
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
-
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
-
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males
-
- Journal Article
- A1
- open access
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations
-
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
-
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
-
Investigation, treatment and monitoring of late-onset hypogonadism in males ISA, ISSAM, and EAU recommendations
-
Tolerability and safety of flutamide in Monotherapy with orchiectomy or with LHRH-a in advanced prostate cancer patients A Belgian multicenter study of 905 patients